Efficacy and safety of induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced non-small cell lung cancer: A retrospective study.

Radiat Oncol · 2025 · PMC11905732 · PMID 40082897

Europe PMC DOI

hedged sentence

0.3940

closest p · 7.9× alpha

0.3940

boldest claim

The sentences

did not reach statistical significancep = 0.394not close (p > 0.1)

Though the PFS for patients receiving consolidation immunotherapy was numerically higher than those without consolidation immunotherapy, the difference did not reach statistical significance (median PFS, 33.6 months vs. 19.7 months; p = 0.394; Fig. 3 D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.